Rodrigo Valderrabano, MD, MSC
Medical Director of Clinical Research, Research Program in Men’s Health, Aging and Metabolism
Member of the Faculty, Harvard Medical School
Dr. Rodrigo Valderrabano is an Endocrinologist and Assistant Professor of Medicine at the Brigham and Women’s Hospital at the Harvard Medical School. He is the Medical Director for the Research Program in Men’s Health Aging and Metabolism where he oversees and conducts research on function promoting therapies including exercise in men an women.
Dr. Valderrabano has a clinical and research focus on metabolic bone disease and aging. During his time as a research fellow at Stanford University, he was awarded the Endocrine Society’s Outstanding Abstract award and the American Society for Bone and Mineral Research’s Young Investigator award for his work studying the links between bone health and hematopoiesis in older men. Previously at the University of Miami, Dr. Valderrabano was the director of the Endocrinology Division Bone Clinic, with a focus on musculoskeletal disease. The ultimate goal of his treatment strategies such as rehabilitation and exercise for osteoporosis, sarcopenia, frailty and other musculoskeletal diseases.
Nancy Latham, PhD, PT
Clinical Research Director
Nancy Latham, PhD, PT completed her training in Physical Therapy at the University of Toronto and McGill University, a PhD at the Clinical Trials Research Unit at the University of Auckland and a NIDRR post- doctoral fellowship in Health Services Research at Boston University. Her research interest is in applying methods from the field of clinical epidemiology, such as randomized controlled trials, cohort studies and meta-analyses, to rehabilitation, aging and disability-related research. She is particularly interested in innovative interventions to extend the benefits of rehabilitation programs to people in the community after usual rehabilitation care ends. She was a co-principal investigator of the HIP Rehab trial, an RCT of a home-based exercise program for the people after hip fracture and was the Study Director of the STRIDE study, a pragmatic randomized controlled trials of a primary care based intervention to reduce serious fall-related injuries in 10 health systems in the U.S.A She is also the PI on studies to evaluate strategies to improve physical activity and decrease social isolation among older people and people with Spinal Cord Injury, and to develop clinical decision support and other technology to improve the delivery of fall prevention programs in primary care. She is a Fellow of the Gerontological Society of America and is on the editorial board of the Journal Physical Therapy.
Grace Huang, MD
Principal Investigator
Instructor in Medicine, Harvard Medical School
MD, Boston University School of Medicine
Growing evidence suggests that prenatal exposure to androgens may play a role in the programming of metabolic dysfunction and cardiovascular disease in adulthood. Evidence from prenatally androgenized animal models exposed to testosterone in early and late gestation demonstrate several cardiometabolic impairments including hypertension, insulin resistance and adiposity in adult life. Pregnant women with polycystic ovary syndrome (PCOS) have higher testosterone levels during pregnancy and delivery compared to healthy mothers and their offspring tend to develop worse metabolic parameters. Despite evidence from animal studies and patient-specific populations (ie. PCOS), data linking prenatal androgens to adult health outcomes in the general human population has not been well studied. The issue of developmental androgenization is of clinical relevance for investigation because of increasing human exposure to endocrine-disrupting environmental factors that interact with androgen receptor signaling. Her research is focused on advancing our understanding of early programming effects of androgens on cardiovascular markers, can help identify biomarkers for human disease, potential therapeutic targets and early periods for intervention.
Monty Montano, PhD
Scientific Director, Boston Pepper Center
Principal Investigator
Assistant Professor of Medicine, Harvard Medical School
PhD, Genetics, Stanford University School of Medicine
Post-doc, Harvard School of Public Health
Monty Montano PhD is a Principal Investigator at Harvard Medical School and the Director of Muscle and Aging Interventions at Brigham and Women’s Hospital. Dr. Montano received a Ph.D. in Genetics from Stanford University School of Medicine and did his postdoctoral work at the Harvard School of Public Health. He conducts international translational research on aging, musculoskeletal regeneration, and chronic HIV infection. Dr. Montano is the principal investigator of an NIH-sponsored 5-year study to comprehensively evaluate physical function and muscle maintenance in older individuals with HIV infection on effective therapy compared to age-matched uninfected individuals. Dr. Montano is a chartered member of the National Institutes of Health Center for Scientific Review and he is the author of a book on translational medicine entitled, “Translational Biology in Medicine: Models from Aging, Muscle Regeneration and Infection.”
Sari Reisner, ScD
Principal Investigator and Director of Transgender Research, Brigham and Women’s Hospital
Assistant Professor of Medicine, Harvard Medical School
Assistant Professor of Epidemiology, Harvard T.H. Chan School of Public Health
Dr. Reisner’s research focuses on health inequities in sexual and gender minority populations (LGBTQ+), concentrating in transgender and gender diverse population health, HIV and other sexually transmitted infections (STIs), mental health and substance use. His work utilizes a participatory population perspective to “work with not “on” communities.
Dr. Reisner is an investigator of multiple funded studies, including by National Institutes of Health (NIH) and the Patient-Centered Outcomes Research Institute (PCORI), among others. He is currently PI of a PCORI-funded multisite longitudinal cohort study of more than 4500 transgender and gender diverse primary care patients to investigate the effect of medical gender affirmation on physical and mental health.
Dr. Reisner has contributed to more than 200 peer-reviewed publications and is founding Associate Research Editor for the Pubmed-indexed Journal Transgender Health. He is also member of the World Association for Transgender Health (WPATH). In 2016, he was profiled in The Lancet as an emerging leader in global transgender population health. He served on the National Academics of Sciences, Engineering and Medicine.
Kieran Reid, PhD, MPH
Exericse Labratory Director
Dr. Kieran F. Reid, PhD, MPH, is the Director of the Laboratory of Exercise Physiology and Physical Performance within the Research Program on Men’s Health, Aging and Metabolism at Brigham and Women’s Hospital and Harvard Medical School. Dr. Reid also serves as the Associate Director of the Function Assessment Core at the Boston Claude D. Pepper Older Americans Independence Center. He has extensive training and experience in conducting clinical trials to assess and restore physical function in aging humans. Dr. Reid has also successfully implemented several award-winning community-based exercise and nutrition interventions to enhance physical and cognitive performance in older adults. In addition to his undergraduate studies in Exercise Physiology, Dr. Reid possesses an MPH degree in Epidemiology and Biostatistics from Tufts University and a PhD degree in Clinical Research from Trinity College Dublin, Ireland.
Amy Larson, MHA
Senior Administrative Director
Division Administrator, Division of Medical Communications
